Related Experiment Videos

Development of medicines for children in Europe: ethical implications

Agnès Saint Raymond1, Daniel Brasseur

  • 1European Medicines Agency, 7 Westferry Circus, Canary Wharf, London E144HB, UK. Agnes.saint-raymond@emea.eu.int

Paediatric Respiratory Reviews
|February 9, 2005
PubMed

Insights

Protecting children in clinical trials is crucial. Ethical research requires studying medicines in pediatric populations, balancing safety with the need for child-specific data.

Area of Science:

  • Pediatric clinical research ethics
  • European regulatory framework for medicines

Background:

  • Children's vulnerability and inability to consent necessitate specific protections in clinical trials.
  • Historical ethical considerations have debated the inclusion of children in research due to these vulnerabilities.

Purpose of the Study:

  • To explore the ethical considerations and legal safeguards for pediatric clinical trials.
  • To address the ethical imperative of studying medicines in children, as adult data is not always applicable.
  • To advocate for high-quality ethical research and public access to information regarding pediatric drug development.

Main Methods:

  • Review of ethical principles governing research with vulnerable populations.
  • Analysis of the European legal framework for pediatric clinical trials.
  • Discussion of the balance between child protection and the need for pediatric-specific medical data.

Main Results:

  • Established ethical principles and European regulations provide safeguards for pediatric trials.
  • Excluding children from trials creates an ethical gap in pediatric pharmacotherapy.
  • There is a collective responsibility to generate safe and reliable data for prescribing medicines to children.

Conclusions:

  • Ethical pediatric clinical research is essential for safe and effective medication use in children.
  • Future European regulations should promote ethical research and transparency in pediatric drug development.
  • Balancing child protection with the need for pediatric-specific medical data is a key ethical challenge.

Keywords:
Biomedical and Behavioral Research

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...